Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Apr 15;16(8):2101-4.
doi: 10.1016/j.bmcl.2006.01.052. Epub 2006 Feb 3.

Synthesis, in Vitro and in Vivo Evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: A Novel Agonist 5-HT1A Receptor PET Ligand

Affiliations
Comparative Study

Synthesis, in Vitro and in Vivo Evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: A Novel Agonist 5-HT1A Receptor PET Ligand

Jaya Prabhakaran et al. Bioorg Med Chem Lett. .

Abstract

Synthesis and in vivo evaluation of 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione (5 or MMT), a high affinity and selective serotonin 5-HT1AR agonist PET tracer, are described. GTPgammaS assay shows that MMT is an agonist with an EC50 comparable to 5-HT. Radiolabeling of 5 was achieved in 30% yield (EOS) from desmethyl-MMT (4) with >99% chemical and radiochemical purities and a specific activity >1000 Ci/mmol. PET studies in baboon show that [11C]5 penetrates the blood-brain barrier but, because of low specific binding and fast clearance of radioactivity it is not a suitable PET tracer for the in vivo quantification of 5-HT1AR.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

LinkOut - more resources

Feedback